ReviewFrontiers in oncology2026
Non-coding RNAs in tumor-educated platelets: emerging roles in cancer progression, biomarker discovery, and therapeutic targeting.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-coding RNAs (ncRNAs) in tumor-educated platelets (TEPs) play an important role in cancer progression. Tumor cells can "educate" platelets, thereby enabling them to participate in multiple stages of tumor development and progression. The ncRNAs carried by TEPs, including microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs), may regulate tumor cell behavior and influence processes such as proliferation, invasion, metastasis, immune regulation, and angiogenesis. Alterations in the expression profiles of these ncRNAs may provide potential biomarkers for early cancer diagnosis, prognosis assessment and treatment monitoring. They may also offer new opportunities for therapeutic intervention. This review summarizes the mechanisms of platelet education by tumor cells, the roles of TEPs in cancer progression, and the functional significance of ncRNAs in TEPs, with particular focus on their contributions to tumor development and progression, their biomarker potential, and their potential as therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.